
February 23, 2023
Hygrovest Limited (ASX: HGV) ("HGV" or the “Company”) is an Australian-listed specialist investment company, which concentrates on producing capital growth for shareholders over the medium term from investments in listed and unlisted equities and other financial assets.
Tender for Investment Manager
As foreshadowed in September 2022, the Independent Directors of HGV wishes to advise that it has undertaken a review of HGV’s operating structure to maximise the value of its investment portfolio having regard to the significant discount which HGV’s share price trades to its net asset value.
The HGV Board has concluded that:
1. The majority of HGV’s investments are unlisted minority interests in cannabis businesses which are more likely to be realised at their fair value in conjunction with a public listing or trade sale of the companies.
2. HGV is reliant on the parties who control these companies to execute a liquidity event.
3. The realisation of these investments is dependent on a material improvement in demand from potential acquirers (both trade and listed equity markets).
4. It is in the interest of HGV shareholders to continue to operate as an ASX listed investment company with an external investment manager to:
a) maximise the value of the current portfolio compared to book value;
b) access the expertise of the Investment Manager (the “Manager”) to maximise returns from redeployment of proceeds from sale of its portfolio; and
c) minimise the level of fixed costs in HGV’s cost structure.
5. HGV will undertake a process to appoint a Manager which is expected to be completed before 30 June 2023.
The current Investment Management Agreement with Parallax Ventures Inc. (“Parallax”) expires on 30 June 2023. HGV has invited Parallax to participate in the tender process to appoint a new Manager. Michael Curtis, a Non-Executive Director and Managing Partner of Parallax will abstain from participating in the appointment of the new Manager.
Realised gains from the sale of HGV’s investments would be distributed in accordance with HGV’s Dividend Policy1. HGV will also consider any proposals to use surplus capital to HGV shareholders in the event that HGV and its Manager are unable to deploy into attractive investment opportunities.
HGV expects the bulk of the Manager’s remuneration would continue to be linked to material increases in HGV’s share price and/or net asset value.
HGV will in due course update shareholders of the outcome of the tender process.
Click here for the full ASX Release
This article includes content from Hygrovest Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
HGV:AU
The Conversation (0)
12 January 2022
Hygrovest Limited
Building a globally diversified portfolio of companies in high-growth industries.
19 September
Cannabis Crossroads: Record US Demand Meets Federal Gridlock
The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
22 July
10 Biggest Cannabis Stocks in the US and Canada in 2025
After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
17 July
Cannabis Market Update: H1 2025 in Review
The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
25 June
Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout
Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
09 May
A State-by-State Guide to Cannabis in Australia
Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...
01 May
New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025
Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve. Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among... Keep Reading...
Latest News
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00